Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus

British Journal of Rheumatology

Volumn 36, Issue 12, 1997, Pages 1283-1289

  Sturfelt, G ^a   Roux Lombard, P ^b   Wollheim, F A ^a   Dayer, J M ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Acute phase response; Interleukin 1 receptor antagonist; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ADULT; ARTHRITIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULONEPHRITIS; HEMOLYTIC ANEMIA; HUMAN; INFLAMMATION; KIDNEY DISEASE; MALE; MYOSITIS; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROTEINURIA; RASH; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; THROMBOCYTOPENIA;

ACUTE-PHASE REACTION; ADULT; AGED; ALBUMINS; CREATININE; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-1;

EID: 0031457105     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dayer J-M, Burger D. Interleukin-1, tumour necrosis factor and their specific inhibitors. Eur Cytokine Netw 1994;5:563-71.
2. 2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest 1986;78:1120-4.
3. Seckinger P, Lowenthal JW, Williamsson K, Dayer J-M, MacDonald HR. A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 1987;139:1546-9.
4. Prieur A-M, Kaufmann M-T, Griscelli C, Dayer J-M. Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet 1987;ii:1240-2.
5. Dayer J-M, Arend WP. Cytokines and growth factors. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology, 5th edn. Philadelphia: WB Saunders, 1997:267-86.
6. Arend WP, Smith MF Jr, Jansson RW, Joslin G. IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol 1991;147:1530-6.
7. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
8. Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systematic lupus erythematosus. Arthritis Rheum 1994;37:1380-5.
9. Becker G, Waldburger M, Hughes GRV. Value of serum C-reactive protein measurement in the investigation of fever in SLE. Ann Rheum Dis 1980;39:50.
10. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute-phase response. Biochem J 1990;265:621-36.
11. Suzuki H, Takemura H, Kashiwagi H. Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus - enhanced production by monocytes and correlation with disease activity. Arthritis Rheum 1995;38:1055-9.
12. Sturfelt G, Sjöholm AG. Complement components, complement activation and acute phase response in Systemic Lupus Erythematosus. Int Arch Allergy Appl Immunol 1984;75:75-83.
13. Jonsson H, Nived O, Sturfelt G. Outcome of systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989;68:141-50.
14. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
15. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of sytemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Emlen W, Jarusiripipat P, Burdick G. A new ELISA for the detection of double-stranded DNA antibodies. J Immunol Methods 1990;132:91-101.
17. Sjöholm AG. Complement components in normal serum and plasma quantitated by electroimmunoassay. Scand J Immunol 1974;20:25-30.
18. Tencer J, Thysell H, Grubb A. Analysis of proteinuria: Reference limits for urine excretion of albumin, protein HC, immunoglobulin G, κ- and λ-immunoreactivity, orosomucoid and α1-antitrypsin. Scand J Clin Lab Invest in press.
19. Gabay C, Gay-Crosier F, Roux-Lombard P et al. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis Arthritis Rheum 1994;37:1744-51.
20. Prieur AM, Dayer A, Roux-Lombard P, Dayer J-M. Levels of cytokine inhibitors: a possible marker of disease activity in childhood dermatomyositis and polymyositis. Clin Exp Rheumatol 1997, in press.
21. Descamps-Latscha B, Herbelin A, Nguyen AT et al. Balance between IL-1β, TNF-α, and their specific inhibitors in chronic renal failure and maintenance dialysis - relationship with activation markers of T cells, B cells and monocytes. J Immunol 1995;154:882-92.
22. Schur PH, Chang D-M, Baptiste P, Uhteg LC, Hanson DC. Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals. Clin Immunol Immunopathol 1990;57:45-63.
23. Hsieh SC, Tsai CY, Sun KH, Tsai YY, Han SH, Yu CL. Defective spontaneous and bacterial lipopolysaccharide-stimulated production of interleukin-1 receptor antagonist by polymorphonuclear neutrophils of patients with active systemic lupus erythematosus. Br J Rheumatol 1995;34:107-12.
24. Sturfelt G, Johnsson U, Sjöholm AG. Sequential studies of complement activation in Systemic Lupus Erythematosus. Scand J Rheumatol 1985;14:184-96.
25. Esdaile JM, Abrahamowicz M, Joseph L, Mackenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum 1996;39:370-8.
26. Nicklin MJH, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 receptor antagonist genes. Genomics 1994;19:382-4.
27. Gabay C, Roux-Lombard P, de Moerloose P, Dayer J-M, Vischer T, Guerne P-A. Absence of correlation between interleukin-6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993;20:815-21.
28. Swaak AJG, Groenwold J, Bronsweld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986;45:359-66.